Clinics in Pennsylvania

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

What Pennsylvania law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Pennsylvania at a glance

Pharmacy regulator: Pennsylvania State Board of Pharmacy (Department of State, Bureau of Professional and Occupational Affairs)
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async allowed
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified clinics serving Pennsylvania

No verified clinics serving Pennsylvania are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Pennsylvania

Yes. A Pennsylvania resident can obtain FDA approved peptides such as semaglutide and tirzepatide from any Pennsylvania-licensed prescriber, including through telemedicine under Act 42 of 2024, Pennsylvania's telemedicine statute, and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy that holds a Pennsylvania pharmacy permit or a Pennsylvania nonresident pharmacy registration from the State Board of Pharmacy. Pennsylvania has no state bulks list, so eligibility of a peptide for compounding follows the FDA framework, and the Board's regulations in 49 Pa. Code chapter 27 govern how Pennsylvania pharmacies compound. [1] [2] [3] [4] [5] [7] [10]

Compounded GLP-1 access in Pennsylvania

Telehealth GLP-1 patients should confirm the dispensing pharmacy holds a Pennsylvania pharmacy permit or nonresident pharmacy registration. [1] [8]

Research use only sellers in Pennsylvania

The Pennsylvania Pharmacy Act restricts dispensing of prescription drugs to licensed pharmacies, and the Controlled Substance, Drug, Device and Cosmetic Act (35 P.S. section 780-101 and following) prohibits the sale of adulterated, misbranded, or unapproved new drugs in the Commonwealth. [4] [6] [9]

How to check a clinic in Pennsylvania

Confirm the prescribing clinician's license with the Pennsylvania medical or nursing board.
Ask which pharmacy compounds or dispenses the peptide and check it in the Pennsylvania State Board of Pharmacy (Department of State, Bureau of Professional and Occupational Affairs) license lookup. [1] [4] [5] [7]
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Pennsylvania. [4] [6] [9]

Common questions in Pennsylvania

Can I get a GLP-1 prescription in Pennsylvania through telemedicine?

Yes. Act 42 of 2024 authorizes Pennsylvania-licensed practitioners to evaluate and prescribe through synchronous or asynchronous telemedicine, as long as the care meets the in-person standard. Semaglutide and tirzepatide are not controlled substances, so no separate in-person requirement applies. [2]

Does the telemedicine prescriber need a Pennsylvania license?

Yes. Act 42 applies to health care practitioners licensed in Pennsylvania. Physicians in other states can obtain a Pennsylvania license through the Interstate Medical Licensure Compact via the State Board of Medicine. Verify the prescriber in the Department of State license lookup before paying. [2] [3] [10]

All peptide legal questions for Pennsylvania